Oral Question·Department of Health and Social Care
“What assessment he has made of the potential effect on access to new medicines of the UK leaving the EU.”
Tabled: 17 October 2018Answered: 23 October 2018
Answering Minister
the Secretary of State for Health and Social Care
Answer from Hansard
The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)
As previously stated, we are boosting investment to unlock new treatments and improve outcomes for brain cancer patients, including investing in cutting-edge equipment to improve access to samples for research. Each pathology service in England maintains its own standard procedures for tissue freezing, which inform local capabilities and practices, and we are investing in England’s pathology networks to deliver productivity and transformation improvements.